Difnal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Difnal

Quick Facts

Property Description
Active ingredient Diclofenac (commonly as Diclofenac sodium)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Origin Synthetic (chemically synthesized)
Common use Relief of pain, inflammation, and fever
Forms Oral solids, injections, topical gels

What Type of Medicine is Difnal?

Difnal is a medicinal preparation whose core active component is Diclofenac, which is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification identifies the drug's primary function in addressing symptoms where inflammation, pain, and fever intersect. This class of medication works by moderating the body's inflammatory cascade. The drug entity is defined by its ability to provide relief through this simultaneous action, and it is often utilized in scenarios such as managing discomfort associated with muscular strain or temporary joint stiffness.

Composition and Origin: Is Diclofenac Synthetic?

The foundation of Difnal is the active component, Diclofenac, a substance that is entirely synthetic, derived chemically as a phenylacetic acid derivative. This establishes it as a product of laboratory synthesis, distinct from natural compounds. Diclofenac formulations are typically manufactured as a single active ingredient product, concentrating the therapeutic action. The medicine is available across several high-level dosage forms, including conventional oral solid forms like tablets, as well as forms for topical application, such as gels. This distinction in forms allows the compound to be utilized for either systemic absorption (acting throughout the body) or localized action (targeting a specific area).

How Does its Action Relate to Pain and Swelling?

The general purpose of Difnal is to reduce discomfort by targeting the physiological action that causes symptoms, rather than merely masking the sensation. As an NSAID, its mechanism involves intervening in the body's pathways that produce inflammatory signals. This focused chemical intervention is designed to reduce both the intensity of the pain sensation and the physical signs of swelling or stiffness. This characterizes the medicine's role in alleviating symptoms stemming directly from underlying inflammatory processes.

Regulatory References

  1. MedlinePlus Diclofenac Information

What side effects are possible with Difnal?

The drug substance designated as Difnal does not possess an established safety profile documented by any major governmental or intergovernmental regulatory authority, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), Health Canada, or the National Institutes of Health (NIH).

Authoritative regulatory documents, including Summary of Product Characteristics (SmPC) or Prescribing Information, are the mandatory basis for structuring and reporting official side effect data. Without such verified regulatory documentation, it is not possible to categorize adverse reactions by frequency (e.g., very common, uncommon) or by System-Organ Class (SOC).

Consequently, the official framework for Difnal, including its known serious adverse reactions, population-specific safety considerations, and any regulatory safety restrictions, is non-existent. Any discussion of possible side effects or safety information outside of official, state-verified documents would constitute unverified commentary and cannot be provided under the required quality standards for medical safety information integrity.

To ensure patient safety and maintain data integrity, only information explicitly grounded in and verified by government regulatory authorities can be reported in this section. As such, the specific safety data for this substance cannot be mapped or detailed.

Overdose and Emergency Response

Overdose Scope

Documented overdose presentations:

  • Nausea, Vomiting, Epigastric pain, Diarrhea, Headache, Drowsiness, and Tinnitus are common manifestations. Physiological systems affected:
  • Gastrointestinal (GI), Renal, Central Nervous System (CNS), Cardiovascular, and Respiratory systems. Dose-related or exposure-related factors:
  • A large overdose can be very harmful to both adults and children. Population-specific overdose notes:
  • GI complications are more serious in the elderly. Patients with pre-existing asthma may face increased risk of breathing trouble during an overdose. Emergency-response statements:
  • Seek immediate medical attention for any suspected overdose. Activated charcoal or gastric lavage may be considered if ingestion was recent. When immediate medical help is required:
  • Urgent care is required for severe manifestations including seizures, coma, little or no urine output, or signs of gastrointestinal bleeding (e.g., vomiting blood or material resembling coffee grounds).

Overdose Classifications (high-level)

Severity classification: Severe and life-threatening outcomes, such as Acute Renal Failure and Convulsions, are documented. Regulatory basis: Approved Prescribing Information and Summary of Product Characteristics. Overdose-context constraints: No specific antidote is known; management is strictly symptomatic and supportive.

Resulting overdose structure

  • Overdose presentations range from common GI complaints to severe, life-threatening CNS and renal failure.
  • Urgent medical attention is required for any suspected overdose and especially for severe documented signs like seizures or internal bleeding.
  • Since no specific antidote is available, all treatment is limited to supportive measures as defined in official labeling.

Connection to the overall overdose profile (2–4 sentences): The regulatory documents define the Diclofenac overdose profile based on a progression from documented GI and CNS manifestations to severe systemic risks like acute renal failure. This profile mandates that individuals seek immediate medical attention for suspected overdose and confirms that management is limited to symptomatic and supportive treatment.

Therapeutic Uses of Difnal

Quick Facts

  • Relieves signs and symptoms associated with osteoarthritis.
  • Addresses symptoms of rheumatoid arthritis.
  • Provides relief for the signs and symptoms of ankylosing spondylitis.
  • Manages moderate acute pain and primary dysmenorrhea (menstrual cramps).

What Difnal Treats: Main Uses and Benefits

Difnal (diclofenac) is a prescribed medication used to address symptoms associated with a variety of conditions where pain and tenderness are present. It serves as a therapeutic option for reducing the signs and symptoms of osteoarthritis and rheumatoid arthritis, which are characterized by joint discomfort and stiffness. The medication also offers relief for ankylosing spondylitis, a chronic condition primarily affecting the spine.

Furthermore, Difnal is utilized for the management of moderate acute pain from various sources. It is also a treatment for symptoms of primary dysmenorrhea (menstrual cramps) in adults. It is important to discuss all therapeutic considerations and goals with a healthcare professional to ensure this is a suitable treatment component.

Eligibility and Restrictions for Use

Who Can and Cannot Use Difnal?

Regulatory labeling establishes clear criteria for the population eligibility of Difnal (Diclofenac). General use is primarily established for adults to treat labeled conditions.


Absolute Contraindications

Difnal is strictly contraindicated for several populations. These include individuals with known hypersensitivity to diclofenac, aspirin-sensitive asthma, or a history of allergic reactions to other NSAIDs. Use is prohibited for patients undergoing Coronary Artery Bypass Graft (CABG) surgery and those with active gastrointestinal ulceration or bleeding. Additionally, patients with severe organ impairment, specifically severe renal failure, severe hepatic failure, or established congestive heart failure (NYHA class II-IV), are excluded from use.


Age and Conditional Restrictions

Safety and efficacy are not established for children younger than approximately 12 years of age. While older adults are generally eligible, caution is indicated due to increased risk. Use is prohibited for women beginning at 30 weeks gestation due to fetal risk, and use is not recommended for patients with established cardiovascular disease. Conditions such as dehydration must be corrected prior to beginning treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Difnal (Diclofenac) has officially documented interaction patterns that span pharmacokinetic and pharmacodynamic mechanisms, leading to specific regulatory constraints.

Interaction Classifications

Classification Interacting Substances (Examples) Official Regulatory Outcome
Contraindicated Other oral Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Increased risk of serious gastrointestinal events
Perioperative pain in CABG surgery setting Increased risk of cardiovascular thrombotic events
Pharmacodynamic Anticoagulants, Antiplatelet agents (e.g., Warfarin, Aspirin), SSRIs/Corticosteroids Additively increases the risk of serious bleeding and GI ulceration
ACE Inhibitors, ARBs, Diuretics May diminish antihypertensive effects and increase risk of renal function deterioration
Pharmacokinetic Voriconazole (CYP2C9 inhibitor) Significantly increases Diclofenac C max (114%) and AUC (78%)
Lithium, Digoxin, Methotrexate May increase plasma concentrations of the co-administered drug by reducing clearance

Interaction-Related Restrictions

Regulatory sources explicitly state that Difnal is contraindicated in the setting of coronary artery bypass graft (CABG) surgery and during the third trimester of pregnancy. Furthermore, co-administration with alcohol increases the documented risk of gastric bleeding, and concomitant use with tobacco may also enhance the risk of serious gastrointestinal adverse events. Population-specific considerations include increased risk for acute renal failure when co-administered with ACE inhibitors or ARBs in elderly or volume-depleted patients, as documented in prescribing information.

Mechanism of Action

Cyclooxygenase Enzyme Inhibition

Difnal acts within domains involving enzyme-mediated signaling by inhibiting the activity of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). This dual, reversible inhibition modifies early molecular steps that normally lead to the enzymatic conversion of arachidonic acid into prostanoids.


Prostanoid Synthesis Suppression

The suppression of the COX enzymes directly modifies the arachidonic acid cascade, limiting the intracellular biosynthesis of specific signaling molecules, including prostaglandins and thromboxanes. This effect alters pathway activity that regulates processes such as pyresis and local vasodilation, influencing signaling sequences that mediate elevated physiological responses.


Peripheral Nociceptive Pathway Modulation

Beyond COX inhibition, Difnal engages mechanisms that regulate processes within the peripheral nervous system. It has been shown to modulate the L-arginine nitric oxide-cGMP pathway and the levels of specific pro-nociceptive neuropeptides, such as Substance P. These actions modify local biochemical conditions that influence the sensitivity and excitability of peripheral nociceptors.

Dosage and Administration Information

The use of Difnal (diclofenac) is based on established clinical guidelines that determine the route, dose, and duration of administration. The active component is available in several forms, including oral tablets (such as Delayed-Release and Extended-Release), powder for oral solution, and preparations for intramuscular (IM) and intravenous (IV) injection. Topical and rectal forms are also available in some regions. The fundamental principle of use for all systemic formulations is the administration of the lowest effective dosage for the shortest duration possible to manage symptoms.


Administration Patterns and Constraints

Oral dosing for chronic conditions like osteoarthritis or rheumatoid arthritis typically ranges from 100 mg to 150 mg daily, usually taken in divided doses (e.g., twice or three times daily). Extended-Release forms are often prescribed for once-daily administration. Dosage for older adults typically starts at the lowest range.

Specific administration requirements are essential for proper use. Delayed-Release and Extended-Release tablets must be swallowed whole and should not be crushed, split, or chewed. Certain immediate-release forms, such as the oral powder, must be mixed with water and consumed on an empty stomach for optimal absorption. Furthermore, the standard use of injectable forms (IM/IV) is limited to a maximum of two days, requiring a transition to an oral or rectal formulation for continued treatment.

Recent Clinical Evidence

Overview of Studies for Difnal

This section provides an overview of the research that has been conducted on Difnal for its approved uses. The information below summarizes the types of studies, the outcomes that research has monitored, and the areas where evidence remains limited or uncertain. Studies help show what has been observed so far, but research does not determine whether an individual will respond similarly.

Evidence for Use in Symptomatic Management of Osteoarthritis

Difnal was studied for use in research exploring the symptoms associated with osteoarthritis, a condition marked by functional limitations and patient-reported outcomes describing perceived discomfort. Researchers conducted randomized controlled trials (RCTs), which were generally short-term, lasting from a few weeks up to a few months.

The research examined specific patient-reported outcomes related to physical discomfort, including changes measured during the study period for scores of pain intensity and daily functioning. Findings describe patterns observed in the studies where measurements in the Difnal group showed numerical differences when compared to the placebo group over the short-term intervals studied.

These reported outcomes reflect the specific conditions under which the studies were conducted. Long-term effects are not fully established because follow-up durations were limited in the core RCTs. Research provides limited insight into long-term outcomes regarding the monitored outcomes for symptom activity or the long-term measurements of function over several years.

Research Examining Comparisons to Other Treatments

Research explored scenarios where Difnal was evaluated in studies that compared it directly against inactive placebo treatments and other active standard therapies. The data from these comparative research scenarios show patterns related to measured changes in symptoms. Findings indicate that the observed patterns varied depending on the specific comparator drug and the study design, and comparative evidence is lacking in some areas.

Frequently Asked Questions (FAQ)

Common questions about Difnal (FAQ)


Q: Does Difnal require special monitoring, like blood tests?

For individuals undergoing prolonged treatment with Difnal, official regulatory documents recommend periodic monitoring. These checks often include evaluations of your blood count, hepatic function (liver), and renal function (kidneys) as general precautionary measures. Your healthcare provider determines the need and frequency of this monitoring based on your specific situation.


Q: Can Difnal affect fertility or family planning?

Official information indicates that Difnal, which belongs to the class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), may impair female fertility. For this reason, its use is generally not recommended for women who are actively trying to conceive. This effect is described in regulatory documents as reversible once the medication is stopped.


Q: Is Difnal meant to be taken regularly or only when needed?

Difnal is officially used for both chronic conditions that require regular, scheduled dosing (like certain types of arthritis) and for acute pain management where it may be taken as needed. Regulatory guidelines emphasize that the medicine is generally used for the shortest possible duration at the lowest effective amount. The specific schedule is determined by the healthcare provider.


Q: Are there different forms or strengths of Difnal?

Yes, regulatory documents confirm that Difnal is available in several forms, which include oral tablets (such as Delayed-Release and Extended-Release), a powder for oral solution, and preparations for injection. These various forms are manufactured in a range of specific milligram strengths to suit different treatment needs.


Q: How quickly does Difnal usually start to work?

Regulatory data on how quickly the drug is absorbed indicates that this varies by the specific formulation used. For some oral forms, the peak level of the medicine in the blood is typically reached within a few hours. Injectable forms are generally described as having a faster onset compared to oral tablets.


Q: Does Difnal continue to work after you stop taking it?

The effect of the drug is primarily related to its presence in the body. Since the unchanged active component has a relatively short half-life of approximately two hours, the drug’s effectiveness generally diminishes as it is eliminated from the body shortly after the last dose.


Q: Does taking Difnal at a certain time of day matter?

The official instructions for certain Difnal formulations, such as the oral powder, specifically require that the medicine be taken on an empty stomach. For most other forms, there is no general restriction related to the time of day, but it is important to follow any directions given on the package label.


Q: What happens if I accidentally miss a day of Difnal?

General patient information for this class of medicine advises taking the missed dose as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose is commonly skipped. Regulatory information indicates a preference for avoiding the taking of two doses close together.


Q: How long can I expect to be on Difnal?

The expected duration of treatment varies significantly depending on the medical condition being addressed. Regulatory documents state that use should be for the shortest possible duration necessary to control symptoms. Continuous long-term use often involves the need for periodic re-evaluation by a health professional.


Q: What is the half-life of Difnal?

According to official prescribing information, the terminal half-life—the time it takes for half of the active component to be eliminated from the body—is approximately two hours.


Q: Are there any long-term effects associated with using Difnal?

Official regulatory warnings indicate that certain risks, particularly cardiovascular risks, may increase based on the dose and the duration of exposure. Because of this, continuous long-term use often involves the need for periodic re-evaluation by a health professional.


Q: What does the research say about Difnal's overall effectiveness?

The clinical studies described in the official label indicate that Difnal has demonstrated efficacy in reducing symptoms like pain and inflammation when compared to a placebo for its approved uses. These findings are the basis for the drug's regulatory approval.


Q: What if I'm using herbal supplements; do they interact with Difnal?

Official drug labels primarily focus on interactions with prescription drugs. However, government-published patient information often includes statements about reviewing all medicines and supplements, including herbal products, with a health professional to review any potential for unintended interactions.


Q: Can older adults use Difnal?

Official regulatory information states that older adults are generally eligible to use Difnal. However, caution is indicated in this population due to an increased risk of adverse reactions, particularly in patients who are frail or have low body weight. Starting at a lower dose is often indicated.


Q: What does 'pharmacological class' mean?

The pharmacological class is the official scientific category that describes how a medicine works in the body. Difnal belongs to the Nonsteroidal Anti-inflammatory Drug (NSAID) class, meaning its primary function is to reduce inflammation, pain, and fever through a common mechanism.


Q: Can I take Difnal with my blood pressure medicine?

Regulatory documents state that Difnal has documented interactions with several classes of blood pressure medications, including ACE inhibitors, ARBs, and diuretics. These interactions may reduce the effectiveness of the blood pressure medicine and increase the potential for kidney-related issues.


Q: Does Difnal interact with alcohol?

Yes, official regulatory warnings explicitly advise against the co-administration of alcohol with Difnal. This combination has been documented to increase the risk of serious gastrointestinal adverse events, including bleeding.


Q: Is there a risk of dependence or addiction with Difnal?

According to regulatory standards, Difnal is not classified as a controlled substance. Official information does not associate this medication with the regulatory classifications of dependence or addiction.


Q: Is Difnal known to cause mood changes or feel like it affects my thinking?

Regulatory documents list a number of central nervous system (CNS) effects that have been reported by patients using the medication. These reported effects may include general changes in mood, dizziness, or headache.


Q: Can Difnal affect my ability to drive or operate machinery?

Individuals who experience certain adverse reactions, such as dizziness or visual disturbances, may find that their ability to drive or operate machinery is affected. Regulatory documents describe that individuals experiencing these effects should avoid driving or operating machinery.


Q: Why do people online say that Difnal is used for [Minor Off-Label Condition]?

Difnal is only officially approved and labeled for specific, recognized uses that have been reviewed by regulatory agencies. Information found on non-official websites may refer to non-approved uses, which are not supported by the official regulatory label.


Q: Do I need to change my diet while using Difnal?

There is no general, overarching change required for most diets. However, depending on the form, some oral tablets have instructions to be taken with food, while the oral powder specifically requires being taken on an empty stomach for better absorption.


Q: Are there any common foods or drinks that should be avoided with Difnal?

Regulatory warnings specifically advise against the co-administration of alcohol due to the increased risk of gastrointestinal bleeding. There are no other common foods or drinks widely restricted across all formulations in the official documents.


Q: Is there a generic version of Difnal available?

Yes. The active ingredient in Difnal, which is diclofenac, is available in multiple generic formulations that have been reviewed and approved by regulatory bodies.


Q: What does the term 'peripheral nociceptive pathway modulation' mean?

This technical term from the drug's mechanism of action describes how the medicine works on the peripheral nerves—those outside of the brain and spinal cord. Essentially, it means the drug helps regulate the sensitivity of the nerves that are responsible for transmitting pain signals.

How should Difnal be stored and disposed of?

The official storage and disposal requirements for Diclofenac Sodium (Difnal) tablets ensure the medicine's integrity and public safety.

Requirement Official Regulatory Statement
Storage Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F).
Protection Must be protected from light and moisture and kept in a tight, light-resistant container.
Child Safety Keep out of the sight and reach of children.
Disposal Utilize a drug take-back program. If unavailable, mix the unused medicine with an undesirable substance (e.g., dirt, coffee grounds) and seal it for disposal in household trash. Do not flush down the toilet or pour down a sink drain.

The storage conditions define the necessary temperature control and container specifications to maintain the product's quality. Disposal instructions outline the mandatory steps for safely discarding expired or unused medication, preventing environmental contamination and accidental exposure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Difnal found in:

A-Z Index: